Bulletin
Investor Alert

Centene Corp.

NYS: CNC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 22, 2020, 7:28 p.m.

CNC
/zigman2/quotes/208900023/composite

$

64.88

Change

+0.04 +0.06%

Volume

Volume 73,651

Quotes are delayed by 20 min

/zigman2/quotes/208900023/composite

Previous close

$ 65.65

$ 64.84

Change

-0.81 -1.23%

Day low

Day high

$64.69

$66.27

Open

52 week low

52 week high

$41.62

$74.70

Open

Mark J. Brooks

Presently, Mark J. Brooks holds the position of Chief Information Officer & Executive VP of Centene Corp.

In the past he was Chief Information Officer of Health Net, Inc.

Mr. Brooks received an MBA and an undergraduate degree from the University of California, Davis.

Transactions

Date Shares Transaction Value
03/24/2020 20,000   Award at $45.55 per share. 911,000
02/04/2020 14,624   Derivative/Non-derivative trans. at $62.88 per share. 919,558
02/04/2020 13,920   Award at $28.13 per share. 391,569
12/26/2019 2,947   Disposition at $63.34 per share. 186,663
12/13/2019 2,387   Derivative/Non-derivative trans. at $58.52 per share. 139,688
12/12/2019 1,766   Derivative/Non-derivative trans. at $58.64 per share. 103,559
12/11/2019 1,910   Derivative/Non-derivative trans. at $59.62 per share. 113,875
12/10/2019 40,000   Award at $59.17 per share. 2,366,800
03/24/2019 2,984   Derivative/Non-derivative trans. at $57.14 per share. 170,506
12/18/2018 2,540   Disposition at $121.26 per share. 308,001
12/13/2018 1,207   Derivative/Non-derivative trans. at $134.29 per share. 162,089
12/12/2018 893   Derivative/Non-derivative trans. at $132.83 per share. 118,618
12/11/2018 16,000   Award at $132.46 per share. 2,119,360
07/02/2018 1,407   Derivative/Non-derivative trans. at $123.21 per share. 173,357
03/24/2018 1,122   Derivative/Non-derivative trans. at $101.47 per share. 113,850
03/12/2018 4,165   Disposition at $102.27 per share. 425,955
12/13/2017 1,279   Derivative/Non-derivative trans. at $100.86 per share. 129,000
12/12/2017 14,800   Award at $99.7 per share. 1,475,560
07/02/2017 1,365   Derivative/Non-derivative trans. at $79.88 per share. 109,037
06/02/2017 2,161   Disposition at $75.43 per share. 163,005
03/24/2017 1,112   Derivative/Non-derivative trans. at $65.31 per share. 72,625
02/21/2017 1,398   Derivative/Non-derivative trans. at $67.61 per share. 94,519
12/13/2016 20,000   Award at $56.26 per share. 1,125,200
12/01/2016 1,099   Disposition at $58 per share. 63,742
11/12/2016 1,051   Derivative/Non-derivative trans. at $50.68 per share. 53,265
10/31/2016 703   43,840
07/02/2016 1,035   Derivative/Non-derivative trans. at $71.29 per share. 73,786
06/06/2016 3,914   Disposition at $65.01 per share. 254,450

Officers and Executives

Mr. Michael F. Neidorff
Chairman, President & Chief Executive Officer
Ms. Brandy Burkhalter
Chief Operating Officer & Executive Vice President
Mr. Jeffrey A. Schwaneke
Chief Financial Officer, Treasurer & Executive VP
Dr. Ken Yamaguchi
Chief Medical Officer & Executive Vice President
Dr. Mary V. Mason
Chief Medial Officer & Senior Vice President
Mr. Mark J. Brooks
Chief Information Officer & Executive VP
Mr. Kenneth A. Burdick
Executive Vice President-Products & Markets
Mr. David P. Thomas
Executive Vice President-Markets
Ms. Kathleen Hodson
Vice President-Staff Business Operations
Dr. Robert C. Packman
Senior Vice President-Medical Affairs
Ms. Holly Benson
Executive Vice President
Mr. Jesse N. Hunter
Chief Strategy Office, EVP-Mergers & Acquisition
Mr. Kevin J. Counihan
Senior Vice President-Products
Mr. Anand Shukla
SVP-Commercial Solutions
Mr. Arvan See Wing Chan
Regional Vice President & Corporate Operations
Mr. Brent Davis Layton
Chief Business Development Officer & EVP
Mr. Claudio Abreu
Executive Vice President
Mr. Steven J. Sell
CEO & Plan President-CA Market
Mr. Patrick J. Frawley
Senior Vice President-Social Responsibility
Mr. Matthew Snyder
SVP-Internal Audit, Compliance & Risk Management
Ms. Lori J. Robinson
Director
Mr. William L. Trubeck
Director
Mr. H. James Dallas
Director
Mr. Christopher R. Isaak
Chief Accounting Officer, Senior VP & Controller
Ms. Jennifer Gilligan
Senior Vice President-Investor Relations
Mr. Chris Koster
Secretary, Senior Vice President & General Counsel
Mr. David L. Steward
Independent Director
Mr. Robert K. Ditmore
Independent Director
Mr. Tommy George Thompson
Independent Director
Mr. Orlando Lozano Ayala
Independent Director
Mr. Richard A. Gephardt
Independent Director
Mr. John R. Roberts
Independent Director
Mr. Frederick H. Eppinger
Independent Director
Ms. Jessica L. Blume
Independent Director
Link to MarketWatch's Slice.